THE RELATIONSHIP BETWEEN TUMOR MASS AND RESISTANCE TO CHEMOTHERAPY: IMPLICATIONS FOR SURGICAL ADJUVANT TREATMENT OF CANCER = RELATIONS ENTRE LA MASSE TUMORALE ET LA RESISTANCE A LA CHIMIOTHERAPIE. APPLICATIONS AUX TRAITEMENTS ADJUVANTS A LA CHIRURGIE DES TUMEURS MALIGNESDEVITA VT JR.1983; CANCER; ISSN 0008-543X; USA; DA. 1983; VOL. 51; NO 7; PP. 1209-1220; ABS. ENG; BIBL. 61 REF.; GRAPHArticle

HODGKIN'S DISEASE: AN OVERVIEWLEWIS BJ; DEVITA VT JR.1978; SOUTH. MED. J.; USA; DA. 1978; VOL. 71; NO 12; PP. 1546-1552; BIBL. 26 REF.Article

THE EVOLUTION OF PRIMARY MULTIMODALITY TREATMENT IN RESECTABLE BREAST CANCERHENNEY JE; DEVITA VT JR.1980; CANCER; ISSN 0008-543X; USA; DA. 1980; VOL. 46; NO 4; PP. 999-1008; BIBL. 36 REF.Article

LYMPHOMASLONGO DL; DEVITA VT JR.1982; CANCER CHEMOTHERAPY; ISSN 505242; NLD; DA. 1982; NO 4; PP. 197-234; BIBL. 209 REF.Article

THE DESIGN OF CLINICAL TRIALS IN THE THERAPY OF OVARIAN CARCINOMAYOUNG RC; DEVITA VT JR.1974; AMER. J. OBSTETR. GYNECOL.; U.S.A.; DA. 1974; VOL. 120; NO 8; PP. 1012-1024; BIBL. 37 REF.Article

MULTIMODAL TREATMENT OF PRIMARY BREAST CARCINOMA: ANALYSIS OF ACCOMPLISHMENTS AND PROBLEM AREASWEISS RB; HENNEY JE; DEVITA VT JR et al.1981; AM. J. MED.; ISSN 0002-9343; USA; DA. 1981; VOL. 70; NO 4; PP. 844-851; BIBL. 69 REF.Article

THE ROLE OF COMBINED MODALITY THERAPY IN THE TREATMENT OF STAGE IIIA HODGKIN'S DISEASEDEVITA VT JR; PROSNITZ LR; GLICK JH et al.1979; INTERNATION. J. RAD. ONCOL. BIOL. PHYS.; USA; DA. 1979; VOL. 5; NO 6; PP. 913-914; BIBL. 6 REF.Article

SCREENING OF ANTICANCER DRUGS. V: HISTORICAL DEVELOPMENT AND CURRENT STRATEGY OF THE NATIONAL CANCER INSTITUTE DRUG DEVELOPMENT PROGRAMGOLDIN A; SCHEPARTZ SA; VENDITTI JM et al.1979; METHODS CANCER RES.; USA; DA. 1979; VOL. 16; PP. 165-245; BIBL. 4 P.Article

PHARMACOKINETIC RATIONALE FOR PERITONEAL DRUG ADMINISTRATION IN THE TREATMENT OF OVARIAN CANCER.DEDRICK RL; MYERS CE; BUNGARY PM et al.1978; CANCER TREATM. REP.; U.S.A.; DA. 1978; VOL. 62; NO 1; PP. 1-11; BIBL. 24 REF.Article

MENINGEAL LEUKEMIA IN THE BLASTIC PHASE OF CHRONIC GRANULOCYTIC LEUKEMIA = LEUCEMIE MENINGEE A LA PHASE BLASTIQUE D'UNE LEUCEMIE GRANULOCYTAIRE CHRONIQUESCHWARTZ JH; CANELLOS GP; YOUNG RC et al.1975; AMER. J. MED.; U.S.A.; DA. 1975; VOL. 59; NO 6; PP. 819-828; BIBL. 23 REF.Article

CLINICAL PHARMACOLOGY OF CYCLOPHOSPHAMIDE = PHARMACOLOGIE CLINIQUE DU CYCLOPHOSPHAMIDEBAGLEY CM JR; BOSTICK FW; DEVITA VT JR et al.1973; CANCER RES.; U.S.A.; DA. 1973; VOL. 33; NO 2; PP. 226-233; BIBL. 30REF.Serial Issue

A DECADE OF COMBINATION CHEMOTHERAPY OF ADVANCED HODGKIN'S DISEASEDEVITA VT JR; CANELLOS GP; MOXLEY JH III et al.1972; CANCER; U.S.A.; DA. 1972; VOL. 30; NO 6; PP. 1495-1504; BIBL. 35 REF.Serial Issue

DIBROMOMANNITOL IN THE THREATMENT OF CHRONIC GRANULOCYTIC LEUKEMIA: A PROSPECTIVE RANDOMIZED COMPARISON WITH BUSULFANCANELLOS GP; YOUNG RC; NIEMAN PE et al.1975; BLOOD; U.S.A.; DA. 1975; VOL. 45; NO 2; PP. 197-203; BIBL. 16REF.Article

CHARACTERISTICS OF BLASTCRISIS IN CHRONIC GRANULOCYTIC LEUKEMIA.ROSENTHAL S; CANELLOS GP; DEVITA VT JR et al.1977; BLOOD; U.S.A.; DA. 1977; VOL. 49; NO 5; PP. 705-714; BIBL. 1 P. 1/2Article

UNDIFFERENTIATED NON-HODGKIN'S LYMPHOMAS (BURKITT'S AND NON-BURKITT'S TYPES): THE RELEVANCE OF MAKING THIS HISTOLOGIC DISTINCTIONMILIAUSKAS JR; BERARD CW; YOUNG RC et al.1982; CANCER; ISSN 0008-543X; USA; DA. 1982; VOL. 50; NO 10; PP. 2115-2121; BIBL. 19 REF.Article

PROGNOSTIC FACTORS FOR ADVANCED DIFFUSE HISTIOCYTIC LYMPHOMA FOLLOWING TREATMENT WITH COMBINATION CHEMOTHERAPY.FISHER RI; DEVITA VT JR; JOHNSON BL et al.1977; AMER. J. MED.; U.S.A.; DA. 1977; VOL. 63; NO 2; PP. 177-182; BIBL. 14 REF.Article

AMERICAN BURKITT'S LYMPHOMA: A CLINICOPATHOLOGIC STUDY OF 30 CASES. II. PATHOLOGIC CORRELATIONS = LYMPHOME DE BURKITT AMERICAIN: UNE ETUDE ANATOMOPATHOLOGIQUE DE 30CAS. II. LES ASPECTS PATHOLOGIQUESBANKS PM; ARSENEAU JC; GRALNICK HR et al.1975; AMER. J. MED.; U.S.A.; DA. 1975; VOL. 58; NO 3; PP. 322-329; BIBL. 22REF.Article

INDOMETHACIN-RESPONSIVE HYPERCALCEMIA IN A PATIENT WITH RENAL-CELL ADENOCARCINOMA = HYPERCALCEMIE SENSIBLE A L'INDOMETHACINE CHEZ UN MALADE AVEC UN EPITHELIOMA GLANDULAIRE CELLULO-RENALBRERETON HD; HALUSHKA PV; ALEXANDER RW et al.1974; NEW ENGL. J. MED.; U.S.A.; DA. 1974; VOL. 291; NO 2; PP. 83-85; BIBL. 10REF.Article

CENTRAL NERVOUS SYSTEM COMPLICATIONS OF NON-HODGKIN'S LYMPHOMA: THE POTENTIAL ROLE OF PROPHYLACTIC THERAPYYOUNG RC; HOWSER DM; ANDERSON T et al.1979; AMER. J. MED.; USA; DA. 1979; VOL. 66; NO 3; PP. 435-443; BIBL. 30 REF.Article

HIGH DOSE INTRAVENOUS BLEOMYCIN IN THE TREATMENT OF ADVANCED LYMPHOMAS.HUBBARD SP; CHABNER BA; CANELLOS GP et al.1975; EUROP. J. CANCER; G.B.; DA. 1975; VOL. 11; NO 9; PP. 623-626; BIBL. 9 REF.Article

AMERICAN BURKITT'S LYMPHOMA: A CLINICOPATHOLOGIC STUDY OF 30 CASES. I. CLINICAL FACTORS RELATING TO PROLONGED SURVIVAL = LYMPHOME DE BURKITT AMERICAIN: UNE ETUDE ANATOMOCLINIQUE DE 30CAS. I. FACTEURS CLINIQUES LIES A UNE SURVIE PROLONGEEARSENEAU JC; CANELLOS GP; BANKS PM et al.1975; AMER. J. MED.; U.S.A.; DA. 1975; VOL. 58; NO 3; PP. 314-321; BIBL. 23REF.Article

CURRENT RESULTS OF THE SCREENING PROGRAM AT THE DIVISION OF CANCER TREATMENT, NATIONAL CANCER INSTITUTEGOLDIN A; VENDITTI JM; MACDONALD JS et al.1981; EUR. J. CANCER; ISSN 0014-2964; GBR; DA. 1981; VOL. 17; NO 2; PP. 129-142; BIBL. 32 REF.Article

ERYTHROCYTE OSMOTIC FRAGILITY IN PATIENTS RECEIVING HYPERTHERMIA WITH AND WITHOUT CHEMOTHERAPYWHANG PENG J; LEES DE; SCHUETTE WH et al.1981; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1981; VOL. 65; NO 11-12; PP. 1103-1104; BIBL. 6 REF.Article

NATURAL HISTORY OF MALIGNANT LYMPHOMAS WITH DIVERGENT HISTOLOGIES AT STAGING EVALUATIONFISHER RI; JONES RB; DEVITA VT JR et al.1981; CANCER; ISSN 0008-543X; USA; DA. 1981; VOL. 47; NO 8; PP. 2022-2025; BIBL. 13 REF.Article

PERSISTENT IMMUNOLOGIC ABNORMALITIES IN LONG-TERM SURVIVORS OF ADVANCED HODGKIN'S DISEASEFISHER RI; DEVITA VT JR; BOSTICK F et al.1980; ANN. INTERN. MED.; USA; DA. 1980; VOL. 92; NO 5; PP. 595-599; BIBL. 25 REF.Article